Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
TG Therapeutics Inc (NASDAQ: TGTX) closed the day trading at $30.05 down -3.25% from the previous closing price of $31.06. In other words, the price has decreased by -$3.25 from its previous closing price. On the day, 2.46 million shares were traded. TGTX stock price reached its highest trading level at $31.3899 during the session, while it also had its lowest trading level at $29.665.
Ratios:
For a better understanding of TGTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 4.59. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 03 ’25 when Power Sean A bought 11,337 shares for $30.29 per share.
Lonial Sagar sold 5,000 shares of TGTX for $152,200 on Nov 11 ’24. The Director now owns 100,195 shares after completing the transaction at $30.44 per share. On Nov 11 ’24, another insider, Charney Laurence N, who serves as the Director of the company, sold 25,000 shares for $30.20 each. As a result, the insider received 754,875 and left with 212,479 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 4677732864 and an Enterprise Value of 4226031104. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.09 while its Price-to-Book (P/B) ratio in mrq is 24.36. Its current Enterprise Value per Revenue stands at 15.96 whereas that against EBITDA is -10357.919.
Stock Price History:
Over the past 52 weeks, TGTX has reached a high of $36.84, while it has fallen to a 52-week low of $12.84. The 50-Day Moving Average of the stock is -1.88%, while the 200-Day Moving Average is calculated to be 36.32%.
Shares Statistics:
Over the past 3-months, TGTX traded about 2.87M shares per day on average, while over the past 10 days, TGTX traded about 1749580 shares per day. A total of 155.78M shares are outstanding, with a floating share count of 140.50M. Insiders hold about 9.74% of the company’s shares, while institutions hold 65.45% stake in the company. Shares short for TGTX as of 1734048000 were 27139751 with a Short Ratio of 9.45, compared to 1731628800 on 28328140. Therefore, it implies a Short% of Shares Outstanding of 27139751 and a Short% of Float of 19.259999999999998.
